Resource

 

 

 

 

 

 

 

 

 

 

 

M&A: Acquiror's Counsel

Acquisition of Rollon Group

13 Dec 2013

Simmons & Simmons has advised Chequers Capital and IGI SGR in relation to the acquisition of Rollon Group from Ardian (formerly Axa Private Equity), Consilium and a group of managers.

Rollon has been a leading international linear motion manufacturer since 1975, providing linear bearings, actuators, and linear motion products.

DLA Piper advises HomeAway on A$220 million Stayz acquisition

13 Dec 2013

DLA Piper has advised NASDAQ listed HomeAway Inc on its purchase of Stayz Pty Ltd, a wholly-owned subsidiary of Fairfax Media Limited [ASX:FXJ], for A$220 million, making it one of the most significant M&A deals in the technology, media & telecommunications sector in Australia in 2013.

HomeAway is an international online vacation rental marketplace operating across the United States, Europe, Asia and South America.

Clifford Chance advises Amdipharm Mercury (AMCo) on its acquisition of Abcur

12 Dec 2013

Clifford Chance has advised Amdipharm Mercury (AMCo) on its acquisition of Sweden-based Abcur AB. Abcur is a specialty pharmaceutical business with a focus on the development, registration and marketing of a wide range of specialised prescription and non-prescription products within the Nordic markets for a number of therapeutic indications including addiction, intensive care, pain management and anaesthesia.

Earlier this year, Clifford Chance advised AMCo on its acquisition of the Fucithalmic pharmaceutical product business of Danish LEO Pharma A/S.

Proposed US$435m Acquisition of the Valerus Field Solutions Business by Kentz Corporation Limited

12 Dec 2013

Simmons & Simmons is advising Kentz Corporation Limited, the holding company of the Kentz engineering and construction group, in relation to its proposed acquisition of the Valerus field solutions business.

Kentz is a global engineering specialist solutions provider, which serves a blue chip client base primarily in the oil and gas, petrochemical and mining and metals sectors. The Group has over 14,500 employees in 30 countries and is listed on the London Stock Exchange (symbol: KENZ).

Olswang helps Studiocanal to acquire top indie UK TV company

12 Dec 2013

Olswang has advised leading European film producer and distributor Studiocanal on the acquisition of its majority stake in one of the UK's most successful independent producers, Red Production Company. The acquisition is part of Studiocanal's strategy to move into the UK TV industry.

Red has produced some of the UK's most popular and critically acclaimed drama series: from the ground-breaking Queer as Folk for Channel 4, to the ratings-winning Scott & Bailey for ITV and most recently, the double BAFTA-winning Last Tango in Halifax.

Burges Salmon advises Gooch & Housego on the acquisition of two companies

12 Dec 2013

Burges Salmon has advised specialist optical components and systems manufacturer Gooch & Housego Plc on the acquisition of two companies.

Gooch & Housego acquired the entire issued share capital of Spanoptic Limited, a Glenrothes Scotland-based manufacturer of precision optical components, and of Constelex Technology Enablers Limited, an Athens, Greece-based designer and manufacturer of optical fibre amplifiers and lasers.

Travers Smith advises Kester Capital LLP on the acquisition of Frontier

12 Dec 2013

Travers Smith private equity partner Paul Dolman has advised a newco funded by funds advised by Kester Capital LLP on the management buyout of Frontier Medical Products Limited ("Frontier").

Founded in 1966, Frontier has grown to become a leading manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and continental Europe.  Frontier is based in Wales and employs over 250 people.

Norton Rose Fulbright advises Beijing Capital Land Ltd. on HK$351.12 million takeover of Juda International Holdings Limited

11 Dec 2013

Norton Rose Fulbright is advising Beijing Capital Land Limited and Beijing Capital Group on an acquisition of approximately 66 per cent of the issued share capital of Juda International Holdings Limited.

The transaction is for a total consideration of HK$351.12 million and will trigger a general offer obligation on Beijing Capital Land for acquiring all the shares not already owned by itself and its concert parties. HSBC is the financial adviser to Beijing Capital Land Limited in its capacity as the offeror.

Eversheds advises Recordati Spa on 67% share acquisition of Tunisian pharmaceutical company Opalia Pharma

11 Dec 2013

Law firm Eversheds has advised Recordati Spa, a major Italian group of pharmaceutical laboratories, on the acquisition of 67% of shares in Tunisian pharmaceutical company Opalia Pharma.

Milan-based Recordati is a specialty pharmaceutical group with a global reach. Opalia Pharma S.A. is a Tunisian pharmaceutical company that markets branded generic drugs with leading products in dermatology and in the gastrointestinal and respiratory therapeutic areas.